SNMMI 2026 Highlights: Molecular Imaging Takeaways with Michael Hofman

Expert commentary from Michael Hofman summarizes key molecular imaging themes from the 2026 SNMMI annual meeting. Specific findings and data not reported in source; full details require access to the original interview.

• Content type is trade-press interview/conference recap — no primary data, CIs, or p-values are available from the snippet provided.
• Michael Hofman (MBBS, FRACP) is a recognized expert in theranostics and PSMA imaging; his commentary likely covers advances in radiopharmaceutical therapy and diagnostic tracers (exact topics not confirmed in source).
• Readers seeking evidence-based takeaways should consult primary SNMMI 2026 abstracts directly, as interview summaries may reflect selective emphasis.

RadPigeon summaries are original and for information only. They are not clinical advice.